Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Oncology|July 12, 2014
Gemcitabine and docetaxel for epithelioid sarcoma: results from a retrospective, multi-institutional analysisDaniel Pink, Stephan Richter, Sebastian Gerdes, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|December 17, 2015
Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcomaDimosthenis Andreou, Mathias Werner, Daniel Pink, et al.
Cancers|May 11, 2024
What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor EntityMaya Niethard, Carolin Knebel, Andreas Leithner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II studyPeter C Thuss-Patience, Albrecht Kretzschmar, Michael Repp, et al.
Journal of Cancer Research and Clinical Oncology|January 19, 2016
Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantationThomas Neumann, Laila Schneidewind, Thomas Thiele, et al.
Oncology Research and Treatment|June 14, 2022
Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG CohortJens Jakob, Leopold Hentschel, Stephan Richter, et al.
Cancers|March 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa StudyMartin Eichler, Rebekka Hoffmann, Christina Baumgarten, et al.
BMC Cancer|August 11, 2016
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patientsMarkus K Schuler, Sebastian Gerdes, Antje West, et al.
Oncology Research and Treatment|December 22, 2025
Frontline pembrolizumab or methotrexate in elderly, frail, or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-HNSCC) - results of the randomized phase 2 study ELDORANDO (AIO-KHT-0115)Konrad Klinghammer, Ullrich Graeven, Philipp Ivanyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylateEva Wardelmann, Sabine Merkelbach-Bruse, Katharina Pauls, et al.
Pageof 7